Skip to content
Open access

A Comparative Analysis of Multiple Myeloma Disease Burden in China and Globally From 1990 to 2023 and Future Trend Projections

Sep 2026 · Cancer Medicine · Vol 15 · 0 citations · 48 references
Medicine

TL;DR

Trends in the age‐ and sex‐specific burden of MM in China from 1990 to 2023, including incidence, prevalence, mortality, and disability‐adjusted life years (DALYs); projects sex‐specific incidence to 2050; and compares findings globally.

Abstract

Multiple myeloma (MM) is a prevalent hematologic malignancy. A systematic comparison of the temporal trends in MM disease burden between China and the global level is important for optimizing prevention and control strategies. This study describes trends in the age‐ and sex‐specific burden of MM in China from 1990 to 2023, including incidence, prevalence, mortality, and disability‐adjusted life years (DALYs); projects sex‐specific incidence to 2050; and compares findings globally.

Read PDF

Similar papers

Open access Oct 2026

Comparative analysis of the trends in laryngeal cancer disease burden between China and the world from 1990 to 2021

Laryngeal cancer remains an important public health concern, with substantial variation in disease burden across regions, age groups, and sexes. This study aimed to characterize temporal trends in the burden of laryngeal cancer in China from 1990 to 2021 and to compare age- and sex-specific patterns of incidence, preva...

Hong-Ming Liao, Hong-Yong Wang · 0 citations
Open access Oct 2026

Global Burden of Disease Study on the Changing Landscape of Hematologic Malignancies and the Growing Impact of Elevated Body Mass Index — Asia, 1990–2023

What is already known about this topic? Hematologic malignancies constitute a growing health burden in Asia. Their long-term subregional patterns, future trajectories, and the contribution of high body mass index (BMI) have not been comprehensively evaluated within a unified framework. What is added by this report? Fro...

Yuan Wang, Ning Xu, Jing-Jing Guo et al. · 0 citations
Open access Oct 2026

Multiple Myeloma in Mexico, 1990-2023: Trends in Incidence, Mortality, and Disability Burden.

BACKGROUND Multiple myeloma (MM) results in significant mortality and disability; however, long-term trends and forecasts specific to Mexico remain insufficiently characterized. METHODS A secondary analysis of Global Burden of Disease (GBD) estimates for Mexico (1990-2023) was conducted. Incidence, prevalence, deaths...

J. Solis-Poblano, Jorge Luis López-Marthen, Patricia Zagoya-Martínez et al. · 0 citations
Open access Oct 2026

The Burden of Early-Onset Gastric Cancer From 1990 to 2021: A Systematic Analysis for the Global Burden of Disease Study 2021.

BACKGROUND Gastric cancer (GC) is a substantial global health burden, with early-onset gastric cancer (EOGC) posing distinct diagnostic and management challenges in adolescents and young adults. This study evaluated the global burden, temporal trends, and associated factors of EOGC. METHODS Using Global Burden of Dis...

Xin-Ye Cui, Yu-Zhuo Chen, Ze-Yu Jiao et al. · 0 citations
Open access Aug 2026

Temporal Trends in Colorectal Cancer Associated With Type 2 Diabetes Mellitus in U.S. Adults, 1999–2023: A CDC Wonder Database Analysis—A Population‐Based Cross‐Sectional Study

Trends in CRC‐related deaths among individuals with coexisting T2DM in the United States from 1999 to 2023 are analyzed, as well as disparities among different demographic and geographic groups are explored.

Waleed Tariq, Neha Waseem, Mehreen Maka et al. · 0 citations
Oct 2026

Trends and Projections of Esophageal Cancer Incidence and Mortality in China, 1990 to 2050: An Analysis of the Global Burden of Disease Study 2023.

Although China has markedly reduced the esophageal cancer burden since 1990, the post-2020 rebound in incidence calls for intensified surveillance and rapid evaluation of potential drivers.

Peng Su, Yan-Zhao Xu, Shi-Wang Wen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.